Enzymatic Cascade-Powered Urinary Diagnostics for Visual Cancer Monitoring.
A low-cost urine test using simple chemistry could make non-invasive cancer monitoring accessible without specialized equipment.
This paper reports a novel enzymatic cascade assay that enables visual detection of cancer biomarkers from urine, potentially enabling non-invasive cancer monitoring at low cost and without specialized equipment. Published in ACS Nano, the approach is at proof-of-concept stage and would require clinical validation.
What the study was
- Study design
- Proof-of-concept diagnostic assay development (likely in vitro / preclinical)
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- ACS nano
Why it surfaced
High-novelty urinary cancer monitoring platform (ACS Nano); non-invasive approach is a major direction. Design quality capped (likely preclinical proof-of-concept).
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.